Podderživaûŝaâ terapiâ v onkologii., Год журнала: 2025, Номер 2(1), С. 13 - 20
Опубликована: Апрель 7, 2025
Neurologic symptoms caused by drug antitumor therapy remain a problem. The severity and frequency of development this type complications depend on the group, dose, duration use. Effective treatment requires proper approach to diagnosis toxic reactions. Therapy neurologic during should be based personalized due difference in mechanisms degree toxicity for each particular patient.Literature data main groups neurotoxic drugs, their action neurological administration are reviewed.
Язык: Английский